Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on the Effects of Mepolizumab on Nasal Health and Immune Response in Patients with Eosinophilic Granulomatosis with Polyangiitis (eGPA)

    Recruiting

    3 1 1 1
    Investigated Drugs:
    The Netherlands
  • Study on the Effectiveness and Safety of NS-229 for Patients with Eosinophilic Granulomatosis with Polyangiitis

    Recruiting

    2 1
    France Germany Italy Spain
  • Study of Benralizumab Safety, Pharmacokinetics, and Efficacy in Children with Eosinophilic Disease

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    France The Netherlands Poland
  • Study on the Effectiveness of Tezepelumab for Adults with Eosinophilic Granulomatosis with Polyangiitis (EGPA)

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    Italy
  • Study on Mepolizumab and Drug Combination for Patients with Eosinophilic Granulomatosis with Polyangiitis

    Not recruiting

    3 1 1
    France
  • Study on Benralizumab and Mepolizumab for Patients with Eosinophilic Granulomatosis with Polyangiitis (EGPA) Receiving Standard Care

    Not recruiting

    3 1 1
    Belgium France Germany Italy
  • Study on the Effectiveness and Safety of Depemokimab vs. Mepolizumab for Adults with Relapsing or Refractory Eosinophilic Granulomatosis with Polyangiitis

    Not recruiting

    3 1 1
    Investigated Drugs:
    Austria Belgium France Germany Hungary Italy +5